okredo logo
none title certification

MB "ANG Pharma" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

EBITDA margin (%)

Login to see the data

EBIT margin (%)

Login to see the data

Financial statetment report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Working capital requirementinfo
Debt-to-equity ratioinfo
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2021
0
-
0
0
-
-
-
-
-
0
0
0
0
2022
1,549
-
-5,908
-5,908
-
7.81
-3.30
63.65
-381.41
-5,908
19,501
0
13,593
2023
38,045
-
7,853
7,693
-
0.60
14.51
63.90
20.22
1,785
25,906
0
27,691
unlock data icon

Register and

explore Okredo data
2023
38,045
-
7,853
7,693
-
0.60
14.51
63.90
20.22
1,785
25,906
0
27,691
unlock data icon

Register and

explore Okredo data

2023

Turnover (€)

38,045 €Ascended2,356 % *

Sales per employee (€)

-

Profit before tax (€)

7,853 €Ascended233 % *

Net Profit (€)

7,693 €Ascended230 % *

Profit per employee (€)

-

Working capital requirement

0.60 Descended-92.32 % *

Debt-to-equity ratio

14.51 Ascended539.70 % *

Total profitability (%)

63.90 %Ascended0.39 % *

Net profitability (%)

20.22 %Ascended105.30 % *

Equity (€)

1,785 €Ascended130 % *

Amounts Payable And Liabilities (€)

25,906 €Ascended33 % *

Non-current Assets (€)

0 €Ascended- *

CurrentAssets (€)

27,691 €Ascended104 % *

*over the last year starting selected period